ClinicalTrials.gg
RecruitingNCT06945055FAMESUpdated Nov 12, 2026

FAmily Engagement Strategy for Coordinated Specialty Care

An interventional study of FAMES and Control in Family Members and Implementation, sponsored by Washington State University. Recruiting at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Washington State University · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 8 months later.
Updated Nov 12, 2026Enrollment updatedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
450
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 759 studies in Psychotic Disorders with a site in United States — 97 open to participants now, 113 under way, 7 of them phase 3. Psychotic Disorders · United States.

Planned enrollment
26th of 682
450 · median 60
Started
2025
with 22 others
No phase
338 of 759
57 open now
Primary completion
2029-12
later than 96 of 112 live
Registered
716th of 759
by date

Among the 759 studies in Psychotic Disorders with a site in United States, this one is the 26th largest by planned enrollment of the 682 interventional ones that give a count, is one of 23 that started in 2025, is one of 338 with no phase, reaches primary completion later than 96 of the 112 other live ones, and was the 716th registered.

Psychotic Disorders

1,593 studies on the registry are indexed under Psychotic Disorders; 283 are open to participants now.

Browse Psychotic Disorders studies →

Open to participants now

97 of the 759 studies in Psychotic Disorders with a site in United States are open now. Recruiting first, the newest first:

92 more — sign in →

All 97 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 204 Psychotic Disorders studies recruiting now, 53 (26%) set no upper age limit and 142 (70%) stop at 75 or younger; 50 take children under 18; 41 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 759 studies in Psychotic Disorders with a site in United States, or all of them as a file.
02

Study summary

Family members/support persons' engagement in mental health services has been linked to reduced burden and stress and improves engagement and outcomes in individuals in the early stages of psychosis. The goal of FAMES is to address low family member/support person engagement in services. FAMES will also address disparities in coordinated specialty care (CSC) by using a culturally responsive family engagement strategy to be delivered by family peers.

Read the detailed description

The overall goal of this mixed-methods, clustered stepped-wedged designed study is to examine the effectiveness of a family peer implemented in coordinated specialty care programs at engaging family members in services. The use of a family peer is anticipated to increase family member participant's feelings of connectedness, self-efficacy, and motivation which will in turn improve family member participants engagement in scheduled coordinated specialty care services such as family psychoeducation.

Recruitment will consist of dyads compromised of a family member support person and a corresponding individual receiving coordinated specialty care services. Recruitment will occur over two waves, the attention control condition (ACC) and the FAMES condition. The ACC will last for 18 months and will recruit 225 participant dyads during which time family member participants will be contacted weekly for 12 weeks where they will be provided with positively framed messaging, educational materials around psychosis, tips for addressing relevant concerns in areas such as communication and de-escalation, and a list of community-based and online resources and events. The FAMES condition will last for 30 months and will recruit 225 participant dyads during which time family member participants will receive a modified cultural formulation interview, brief check-ins, psychoeducation, and will have access to an online community.

Recruitment will take place at nine coordinated specialty care programs across four states (Washington, Oregon, Tennessee, and New Mexico) which have been randomized to a clustered stepped wedge program design.

03

Conditions studied

  • Family Members
  • Implementation

Browse trials for

Keywords

  • early psychosis
  • family peer
  • engagement
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Family Member / Support Person Inclusion Criteria:

  • Family member/support person of an individual enrolled in coordinated specialty care services for less than or equal to 6 months.
  • 18 years of age or older.
  • During the active implementation period (FAMES) did not participate in the attention control condition.

Exclusion Criteria:

  • If they do not understand the consent process.
  • If they do not speak and/or understand English or Spanish.

Primary Service User Inclusion Criteria

  • enrolled in coordinated specialty care services for less than or equal to 6 months.
  • 15 years of age or older.
  • Has a family member/support person willing to engage in the study. during the active implementation period (FAMES) did not participate in the attention control condition.

Exclusion Criteria

  • if they do not understand the consent process
  • If they do not speak and/or understand English or Spanish
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
450 participants (estimated)

Study arms

  • Active comparator
    Attention Control Condition

    225 dyads (family members/support persons and individuals receiving services for psychosis) will be recruited over a period of 18 months to receive 12 weeks of weekly communication via text, email or phone call, which includes positive messaging, community resources, appointment reminders, and psychoeducation.

    Behavioral: Control

  • Active comparator
    Active Condition

    This arm lasts for 30 months during each wave of the clustered randomized stepped wedge design. 225 participants will receive the FAMES intervention.

    Behavioral: FAMES

Interventions

  • BehavioralFAMES

    225 dyads (family member/support persons and individuals receiving services for psychosis) will be recruited over a period of 30 months. Family member/support persons will be connected to a family peer for a period of 12 weeks who will use the cultural formulated interview to develop rapport and identify unique cultural needs which can inform treatment and resource identification. Participants will receive brief contact, family psychoeducation, and be connected to an online family resource group where they can receive additional support from certified peers and other family member/support persons.

  • BehavioralControl

    participants will receive 12 weeks of automated communication which contain positive messaging, appointment reminders, links to community resources, and coping skills.

06

What researchers measure

Primary outcomes

  1. Engagement in coordinated specialty care psychoeducation

    Will be measured as first session attendance rate and total attendance rate per family provided by administrative data from the coordinated specialty care site partners.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 3 months

  2. Engagement in Family Engagement Strategy

    Total number of Family Engagement Strategy session attended and the total number of contact minutes to measure engagement.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 3 months

Secondary outcomes

  1. Perceived Stress Scale

    A self-report measure which includes 10 Likert-style items to assess the degree to which an individual appraises life as stressful. Scores range from 0-40 where scores greater that 13 indicate moderate to high perceived stress.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  2. General Anxiety Disorder - 7

    Self-report measure to assess symptoms of anxiety. Scores range from 0-21 where scores greater than 10 are indicative of clinically significant anxiety.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  3. Client Engagement

    Provider reported service utilization. Total number of appointments attended.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  4. Client - Patient Health Questionnaire - 9

    A self-report from the individual receiving coordinated specialty care services on their symptoms of depression. Scores range from 0-27 where any score 10 or greater is indicative of clinically significant symptoms of depression.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  5. Family - Patient Health Questionnaire - 9

    A self-report from the family member participant on their symptoms of depression. Scores range from 0-27 where any score 10 or greater is indicative of clinically significant symptoms of depression.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

  6. Community Assessment of Psychic Experiences - Positive Scale 15-items Scale

    A self-report measure from the individual receiving the coordinated specialty care services. Scores range from 0-3 where scores greater than 1.46 indicate clinically significant symptoms of psychosis.

    Time frame: Baseline through study completion; repeated measure to assess change through study completion, average of 6 months

Other outcomes

  1. General Self-Efficacy Scale

    A self-report 10-item measure completed by the family member participant. Scores range from 10-40 with higher scores indicating greater self-efficacy.

    Time frame: Baseline and Month 3 of treatment period; repeated measure to assess change through study completion, an average of 3 months

  2. Social Connectedness subscale of the Youth Services Survey - Families

    Social connectedness will be measured using four questions (e.g., "I know people who will listen and understand me when I need to talk") from the YSS-F. Scores range from 4 to 20, higher scores indicating greater social connectedness.

    Time frame: Baseline and Month 3 of treatment period; repeated measure to assess change through study completion, an average of 3 months

  3. Treatment Motivation Questionnaire

    A self-report measure completed by the family member/support person participant. Includes 26 Likert-scale questions to assess motivation about services. Scores range from 27 to 182 where greater scores indicated greater motivation.

    Time frame: Baseline and Month 3 of treatment period; repeated measure to assess change through study completion, an average of 3 months

07

Study locations

3 of 4 sites recruiting
  • Deschutes County Behavioral Health EASA
    Bend, Oregon 97703, United States
    Not yet recruiting
  • Comprehensive Healthcare
    Pasco, Washington 99301, United States
    Recruiting
  • Lucid Living
    Tacoma, Washington 98418, United States
    Recruiting
  • Comprehensive Healthcare
    Yakima, Washington 98902, United States
    Recruiting
08

References and documents

Publications

  • Oluwoye O, Stokes B, Crisanti AS, Garcia KS, Kriegel L, Puzia M, Sanchez AL, Shelton RC, Weeks DL. FAMily Motivational Engagement Strategy (FAMES) for coordinated specialty care programs: study protocol to evaluate a culturally responsive engagement intervention and equity focused implementation strategies in a hybrid type 2 randomized stepped-wedge trial. Trials. 2025 Dec 16;26(1):568. doi: 10.1186/s13063-025-09280-0. PubMed 41402877 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2025 (actual). Primary completion is estimated for Dec 2029, 57 months after the start.

Of 460 non-industry interventional studies with no phase under Psychotic Disorders, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 52. This study's planned 57 months is above that.

Counting every sponsor, half of 462 studies reached it within 34 months; a quarter within 19 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2025
First posted
Apr 25, 2025
StartActual
Mar 1, 2025
Primary completionEst.
Dec 1, 2029
CompletionEst.
Dec 31, 2029
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Enrollment
900→450
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Enrollment 900→450
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06945055
Lead sponsor
Washington State University
Responsible party
Oladunni Oluwoye (Associate Professor, Washington State University) — Principal investigator
First posted
Apr 25, 2025
Start date
Mar 1, 2025
Primary completion
Dec 1, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Nov 12, 2026

Study contacts

Oladunni Oluwoye, Associate Professor, Ph.D.
Contact
oladunni.oluwoye@wsu.edu
509-368-6805
Bryony Stokes, Program Manager, M.S.
Contact
bryony.mueller@wsu.edu
509-505-7001

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion